News | June 26, 2014

Advanced Alumina Ceramic Finds Niche in Oncology Equipment

June 25, 2014 — Thanks to its excellent dielectric properties and a reliable surface finish, a high-quality alumina ceramic from Morgan Advanced Materials is now being successfully used in radiotherapy equipment for oncology treatment.

Deranox 970 is a high-density, non-porous and vacuum-tight material with a 97 percent aluminium oxide content, which provides excellent electrical insulation. It is frequently used in high-vacuum systems, in laser and microscope applications and as an insulator in medical and scientific equipment, and has now been specified as the sealing element for RF windows in radiotherapy equipment.

Acting as a mechanical seal at either end of the vacuum chamber through which electron beams pass in the radiotherapy process, RF windows maintain the integrity of the vacuum, allowing electrons to pass through while preventing both ingress of contaminants and vacuum leakage.

Yannick Galais from Morgan explained: “While most solutions for RF windows contain around 97 percent alumina, it is the remaining 3 percent that makes all the difference in dielectric performance. The alumina ceramic formulation of Deranox 970 provides a high dielectric constant — 9.85 and 9.84 at 2.8GHz and 2.9GHz respectively — and low loss tangent — 0.00109 and 0.00110 at 2.8GHz and 2.9GHz respectively. Externally tested and verified by an independent and fully accredited testing house to an internationally recognized standard, ASTM D2520, these properties contribute to excellent stability at high frequencies.

“Our sophisticated powder manufacturing processes provide excellent repeatability from batch to batch, between batches, which is a key parameter in tuning the nominal wavelength and beam frequency, which will ultimately determine the performance of the of the radiotherapy machine. Our precision machining capabilities guarantee a consistent surface finish and flatness preventing RF reflectance and thus eliminating heat and leakage over time. Providing an impurity-free surface finish also improves the performance of the radiotherapy machinery by removing any potential for oxidation on the RF window,” Galais said.

Using advanced simulation techniques and extensive modeling, Deranox 970 has been comprehensively tested for radiotherapy applications prior to the prototype stage to ensure its suitability — followed by in-depth real-life testing to ensure optimum performance within a very tight tolerance range. Developed alongside Deranox 970 for radiotherapy equipment, Morgan has also introduced a tailored moly-manganese metalizing ink to facilitate the bonding process when the RF window is brazed to the body of the machine, creating the optimum seal and safeguarding the vacuum. As each RF window is individually designed for specific machinery, Morgan’s inks are custom formulated for each material grade. In addition to the ceramic, Morgan is able to supply the complete RF window sub-assembly including mounting flanges. Innovative design features allow Morgan to offer ceramic RF windows brazed inside the oxygen free copper (OFC) vacuum chamber.

Galais continued, “RF windows made of Deranox 970 will last the lifetime of the radiotherapy equipment — generally 20 years plus. Within the highly time-sensitive oncology treatment pathway, disruption to therapy machinery is simply not an option and failure of an RF window will often require full replacement of the radiotherapy machine, at enormous cost to the hospital trust and causing unacceptable delays for patients. The purity of our Deranox 970 material, coupled with its reliable dielectric properties and Morgan’s extensive modeling and test processes, ensure a high-quality RF window solution with long-lasting performance.”

For more information: www.morganadvancedmaterials.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more